Global Single Domain Antibody(sdAbs) Drugs Market Growth 2026-2032
The global Single Domain Antibody(sdAbs) Drugs market size is predicted to grow from US$ 491 million in 2025 to US$ 1119 million in 2032; it is expected to grow at a CAGR of 12.3% from 2026 to 2032.
Single Domain Antibody Drugs refer to approved and commercially marketed therapeutic drugs whose active molecules are based on single-domain antibody structures. The currently marketed products mainly include Sanofi's Cablivi, Taisho Pharmaceutical's Nanozora, and Envafolimab manufactured by Alphamab Oncology, covering indications such as acquired thrombotic thrombocytopenic purpura, rheumatoid arthritis, and selected advanced solid tumors. Key upstream inputs include engineered expression cell lines, cell culture media, feeds, single-use bioreactor consumables, chromatography resins, ultrafiltration membranes, buffers, sterile filling components, vials or prefilled syringes, stoppers, labels, and cold-chain packaging materials. Major downstream customers include hospitals, specialty treatment centers, oncology departments, hematology departments, rheumatology and immunology departments, pharmaceutical distributors, and public or commercial reimbursement systems. The 2025 global nominal production capacity is estimated at approximately 1.25 million units, actual sales volume at about 728,000 units, average ex-factory price at around USD 690 per unit, and industry gross margin at approximately 68%?82%.
The single-domain antibody drug market is currently in an early commercialization phase, with clear technological advantages but a limited number of marketed products. Existing drugs mainly target rare diseases, rheumatology, and oncology, showing a small-product, high-margin, and highly differentiated market profile. Differences in indications, administration methods, and patient populations create a dispersed yet finely segmented market structure. As indications expand and more candidate drugs gain approval, the market is expected to gradually grow, although near-term expansion remains centered on currently marketed products and is constrained by regulatory approval and hospital access timelines. The global competitive landscape is highly concentrated, with major manufacturers holding technological barriers and patent protections that confer first-mover advantages. Sanofi, Alphamab Oncology, and Taisho Pharmaceutical occupy leading positions in hematology, oncology immunotherapy, and rheumatology, respectively. New entrants face long R&D timelines, clinical validation requirements, and regulatory hurdles, limiting their ability to capture market share in the short term. Competition focuses on product differentiation, clinical application expansion, and production and supply capabilities, with the commercial model revolving around a small number of high-value patients. Future market growth will be driven by indication expansion of marketed products, regional market access, improvements in reimbursement systems, and potential new drug approvals. The structural characteristics of single-domain antibodies provide advantages in subcutaneous administration, tissue penetration, and multispecific design, potentially increasing penetration in rare diseases and specialized oncology immunotherapy. Technological integration, including AI-assisted discovery, high-throughput screening, and optimization platforms, is expected to improve candidate selection efficiency and developability, supporting market expansion. Key barriers remain the limited number of marketed products, narrow indications, long clinical development cycles, strict regulatory requirements, and small patient populations. Some drugs are derived from non-human structures and require humanization and immunogenicity validation. Although single-domain antibodies offer high technological barriers and innovation value, near-term market expansion is limited, and revenue growth depends on market penetration of existing products, indication expansion, and execution capabilities. Overall, market growth is steady but concentrated in a few core products and manufacturers.
LP Information, Inc. (LPI) ' newest research report, the ?Single Domain Antibody(sdAbs) Drugs Industry Forecast? looks at past sales and reviews total world Single Domain Antibody(sdAbs) Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Single Domain Antibody(sdAbs) Drugs sales for 2026 through 2032. With Single Domain Antibody(sdAbs) Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Single Domain Antibody(sdAbs) Drugs industry.
This Insight Report provides a comprehensive analysis of the global Single Domain Antibody(sdAbs) Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Single Domain Antibody(sdAbs) Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Single Domain Antibody(sdAbs) Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Single Domain Antibody(sdAbs) Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Single Domain Antibody(sdAbs) Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Single Domain Antibody(sdAbs) Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Single Domain Antibody(sdAbs) Drugs market?
What factors are driving Single Domain Antibody(sdAbs) Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Single Domain Antibody(sdAbs) Drugs market opportunities vary by end market size?
How does Single Domain Antibody(sdAbs) Drugs break out by Type, by Application?
Single Domain Antibody Drugs refer to approved and commercially marketed therapeutic drugs whose active molecules are based on single-domain antibody structures. The currently marketed products mainly include Sanofi's Cablivi, Taisho Pharmaceutical's Nanozora, and Envafolimab manufactured by Alphamab Oncology, covering indications such as acquired thrombotic thrombocytopenic purpura, rheumatoid arthritis, and selected advanced solid tumors. Key upstream inputs include engineered expression cell lines, cell culture media, feeds, single-use bioreactor consumables, chromatography resins, ultrafiltration membranes, buffers, sterile filling components, vials or prefilled syringes, stoppers, labels, and cold-chain packaging materials. Major downstream customers include hospitals, specialty treatment centers, oncology departments, hematology departments, rheumatology and immunology departments, pharmaceutical distributors, and public or commercial reimbursement systems. The 2025 global nominal production capacity is estimated at approximately 1.25 million units, actual sales volume at about 728,000 units, average ex-factory price at around USD 690 per unit, and industry gross margin at approximately 68%?82%.
The single-domain antibody drug market is currently in an early commercialization phase, with clear technological advantages but a limited number of marketed products. Existing drugs mainly target rare diseases, rheumatology, and oncology, showing a small-product, high-margin, and highly differentiated market profile. Differences in indications, administration methods, and patient populations create a dispersed yet finely segmented market structure. As indications expand and more candidate drugs gain approval, the market is expected to gradually grow, although near-term expansion remains centered on currently marketed products and is constrained by regulatory approval and hospital access timelines. The global competitive landscape is highly concentrated, with major manufacturers holding technological barriers and patent protections that confer first-mover advantages. Sanofi, Alphamab Oncology, and Taisho Pharmaceutical occupy leading positions in hematology, oncology immunotherapy, and rheumatology, respectively. New entrants face long R&D timelines, clinical validation requirements, and regulatory hurdles, limiting their ability to capture market share in the short term. Competition focuses on product differentiation, clinical application expansion, and production and supply capabilities, with the commercial model revolving around a small number of high-value patients. Future market growth will be driven by indication expansion of marketed products, regional market access, improvements in reimbursement systems, and potential new drug approvals. The structural characteristics of single-domain antibodies provide advantages in subcutaneous administration, tissue penetration, and multispecific design, potentially increasing penetration in rare diseases and specialized oncology immunotherapy. Technological integration, including AI-assisted discovery, high-throughput screening, and optimization platforms, is expected to improve candidate selection efficiency and developability, supporting market expansion. Key barriers remain the limited number of marketed products, narrow indications, long clinical development cycles, strict regulatory requirements, and small patient populations. Some drugs are derived from non-human structures and require humanization and immunogenicity validation. Although single-domain antibodies offer high technological barriers and innovation value, near-term market expansion is limited, and revenue growth depends on market penetration of existing products, indication expansion, and execution capabilities. Overall, market growth is steady but concentrated in a few core products and manufacturers.
LP Information, Inc. (LPI) ' newest research report, the ?Single Domain Antibody(sdAbs) Drugs Industry Forecast? looks at past sales and reviews total world Single Domain Antibody(sdAbs) Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Single Domain Antibody(sdAbs) Drugs sales for 2026 through 2032. With Single Domain Antibody(sdAbs) Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Single Domain Antibody(sdAbs) Drugs industry.
This Insight Report provides a comprehensive analysis of the global Single Domain Antibody(sdAbs) Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Single Domain Antibody(sdAbs) Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Single Domain Antibody(sdAbs) Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Single Domain Antibody(sdAbs) Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Single Domain Antibody(sdAbs) Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Single Domain Antibody(sdAbs) Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Cablivi
- Nanozora
- Envafolimab
- Subcutaneous Injection
- Intravenous Injection
- Other
- Online Sales
- Offline Sales
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- Taisho Pharmaceutical
- Alphamab Oncology
What is the 10-year outlook for the global Single Domain Antibody(sdAbs) Drugs market?
What factors are driving Single Domain Antibody(sdAbs) Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Single Domain Antibody(sdAbs) Drugs market opportunities vary by end market size?
How does Single Domain Antibody(sdAbs) Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Single Domain Antibody(sdAbs) Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Single Domain Antibody(sdAbs) Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Single Domain Antibody(sdAbs) Drugs by Country/Region, 2021, 2025 & 2032
2.2 Single Domain Antibody(sdAbs) Drugs Segment by Type
2.2.1 Cablivi
2.2.2 Nanozora
2.2.3 Envafolimab
2.2.4 Single Domain Antibody(sdAbs) Drugs Sales by Type
2.2.4.1 Global Single Domain Antibody(sdAbs) Drugs Sales Market Share by Type (2021-2026)
2.2.4.2 Global Single Domain Antibody(sdAbs) Drugs Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Single Domain Antibody(sdAbs) Drugs Sale Price by Type (2021-2026)
2.3 Single Domain Antibody(sdAbs) Drugs Segment by Administration Route
2.3.1 Subcutaneous Injection
2.3.2 Intravenous Injection
2.3.3 Other
2.3.4 Single Domain Antibody(sdAbs) Drugs Sales by Administration Route
2.3.4.1 Global Single Domain Antibody(sdAbs) Drugs Sales Market Share by Administration Route (2021-2026)
2.3.4.2 Global Single Domain Antibody(sdAbs) Drugs Revenue and Market Share by Administration Route (2021-2026)
2.3.4.3 Global Single Domain Antibody(sdAbs) Drugs Sale Price by Administration Route (2021-2026)
2.4 Single Domain Antibody(sdAbs) Drugs Segment by Sales Channels
2.4.1 Online Sales
2.4.2 Offline Sales
2.4.3 Single Domain Antibody(sdAbs) Drugs Sales by Sales Channels
2.4.3.1 Global Single Domain Antibody(sdAbs) Drugs Sales Market Share by Sales Channels (2021-2026)
2.4.3.2 Global Single Domain Antibody(sdAbs) Drugs Revenue and Market Share by Sales Channels (2021-2026)
2.4.3.3 Global Single Domain Antibody(sdAbs) Drugs Sale Price by Sales Channels (2021-2026)
2.5 Single Domain Antibody(sdAbs) Drugs Segment by Application
2.5.1 Hospital
2.5.2 Clinic
2.5.3 Other
2.5.4 Single Domain Antibody(sdAbs) Drugs Sales by Application
2.5.4.1 Global Single Domain Antibody(sdAbs) Drugs Sale Market Share by Application (2021-2026)
2.5.4.2 Global Single Domain Antibody(sdAbs) Drugs Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Single Domain Antibody(sdAbs) Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Single Domain Antibody(sdAbs) Drugs Breakdown Data by Company
3.1.1 Global Single Domain Antibody(sdAbs) Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Single Domain Antibody(sdAbs) Drugs Sales Market Share by Company (2021-2026)
3.2 Global Single Domain Antibody(sdAbs) Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Single Domain Antibody(sdAbs) Drugs Revenue by Company (2021-2026)
3.2.2 Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Single Domain Antibody(sdAbs) Drugs Sale Price by Company
3.4 Key Manufacturers Single Domain Antibody(sdAbs) Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Single Domain Antibody(sdAbs) Drugs Product Location Distribution
3.4.2 Players Single Domain Antibody(sdAbs) Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SINGLE DOMAIN ANTIBODY(SDABS) DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Single Domain Antibody(sdAbs) Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Single Domain Antibody(sdAbs) Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Single Domain Antibody(sdAbs) Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Single Domain Antibody(sdAbs) Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Single Domain Antibody(sdAbs) Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Single Domain Antibody(sdAbs) Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Single Domain Antibody(sdAbs) Drugs Sales Growth
4.4 APAC Single Domain Antibody(sdAbs) Drugs Sales Growth
4.5 Europe Single Domain Antibody(sdAbs) Drugs Sales Growth
4.6 Middle East & Africa Single Domain Antibody(sdAbs) Drugs Sales Growth
5 AMERICAS
5.1 Americas Single Domain Antibody(sdAbs) Drugs Sales by Country
5.1.1 Americas Single Domain Antibody(sdAbs) Drugs Sales by Country (2021-2026)
5.1.2 Americas Single Domain Antibody(sdAbs) Drugs Revenue by Country (2021-2026)
5.2 Americas Single Domain Antibody(sdAbs) Drugs Sales by Type (2021-2026)
5.3 Americas Single Domain Antibody(sdAbs) Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Single Domain Antibody(sdAbs) Drugs Sales by Region
6.1.1 APAC Single Domain Antibody(sdAbs) Drugs Sales by Region (2021-2026)
6.1.2 APAC Single Domain Antibody(sdAbs) Drugs Revenue by Region (2021-2026)
6.2 APAC Single Domain Antibody(sdAbs) Drugs Sales by Type (2021-2026)
6.3 APAC Single Domain Antibody(sdAbs) Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Single Domain Antibody(sdAbs) Drugs by Country
7.1.1 Europe Single Domain Antibody(sdAbs) Drugs Sales by Country (2021-2026)
7.1.2 Europe Single Domain Antibody(sdAbs) Drugs Revenue by Country (2021-2026)
7.2 Europe Single Domain Antibody(sdAbs) Drugs Sales by Type (2021-2026)
7.3 Europe Single Domain Antibody(sdAbs) Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Single Domain Antibody(sdAbs) Drugs by Country
8.1.1 Middle East & Africa Single Domain Antibody(sdAbs) Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Single Domain Antibody(sdAbs) Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Single Domain Antibody(sdAbs) Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Single Domain Antibody(sdAbs) Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Single Domain Antibody(sdAbs) Drugs
10.3 Manufacturing Process Analysis of Single Domain Antibody(sdAbs) Drugs
10.4 Industry Chain Structure of Single Domain Antibody(sdAbs) Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Single Domain Antibody(sdAbs) Drugs Distributors
11.3 Single Domain Antibody(sdAbs) Drugs Customer
12 WORLD FORECAST REVIEW FOR SINGLE DOMAIN ANTIBODY(SDABS) DRUGS BY GEOGRAPHIC REGION
12.1 Global Single Domain Antibody(sdAbs) Drugs Market Size Forecast by Region
12.1.1 Global Single Domain Antibody(sdAbs) Drugs Forecast by Region (2027-2032)
12.1.2 Global Single Domain Antibody(sdAbs) Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Single Domain Antibody(sdAbs) Drugs Forecast by Type (2027-2032)
12.7 Global Single Domain Antibody(sdAbs) Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Single Domain Antibody(sdAbs) Drugs Product Portfolios and Specifications
13.1.3 Sanofi Single Domain Antibody(sdAbs) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 Taisho Pharmaceutical
13.2.1 Taisho Pharmaceutical Company Information
13.2.2 Taisho Pharmaceutical Single Domain Antibody(sdAbs) Drugs Product Portfolios and Specifications
13.2.3 Taisho Pharmaceutical Single Domain Antibody(sdAbs) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Taisho Pharmaceutical Main Business Overview
13.2.5 Taisho Pharmaceutical Latest Developments
13.3 Alphamab Oncology
13.3.1 Alphamab Oncology Company Information
13.3.2 Alphamab Oncology Single Domain Antibody(sdAbs) Drugs Product Portfolios and Specifications
13.3.3 Alphamab Oncology Single Domain Antibody(sdAbs) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Alphamab Oncology Main Business Overview
13.3.5 Alphamab Oncology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Single Domain Antibody(sdAbs) Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Single Domain Antibody(sdAbs) Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Single Domain Antibody(sdAbs) Drugs by Country/Region, 2021, 2025 & 2032
2.2 Single Domain Antibody(sdAbs) Drugs Segment by Type
2.2.1 Cablivi
2.2.2 Nanozora
2.2.3 Envafolimab
2.2.4 Single Domain Antibody(sdAbs) Drugs Sales by Type
2.2.4.1 Global Single Domain Antibody(sdAbs) Drugs Sales Market Share by Type (2021-2026)
2.2.4.2 Global Single Domain Antibody(sdAbs) Drugs Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Single Domain Antibody(sdAbs) Drugs Sale Price by Type (2021-2026)
2.3 Single Domain Antibody(sdAbs) Drugs Segment by Administration Route
2.3.1 Subcutaneous Injection
2.3.2 Intravenous Injection
2.3.3 Other
2.3.4 Single Domain Antibody(sdAbs) Drugs Sales by Administration Route
2.3.4.1 Global Single Domain Antibody(sdAbs) Drugs Sales Market Share by Administration Route (2021-2026)
2.3.4.2 Global Single Domain Antibody(sdAbs) Drugs Revenue and Market Share by Administration Route (2021-2026)
2.3.4.3 Global Single Domain Antibody(sdAbs) Drugs Sale Price by Administration Route (2021-2026)
2.4 Single Domain Antibody(sdAbs) Drugs Segment by Sales Channels
2.4.1 Online Sales
2.4.2 Offline Sales
2.4.3 Single Domain Antibody(sdAbs) Drugs Sales by Sales Channels
2.4.3.1 Global Single Domain Antibody(sdAbs) Drugs Sales Market Share by Sales Channels (2021-2026)
2.4.3.2 Global Single Domain Antibody(sdAbs) Drugs Revenue and Market Share by Sales Channels (2021-2026)
2.4.3.3 Global Single Domain Antibody(sdAbs) Drugs Sale Price by Sales Channels (2021-2026)
2.5 Single Domain Antibody(sdAbs) Drugs Segment by Application
2.5.1 Hospital
2.5.2 Clinic
2.5.3 Other
2.5.4 Single Domain Antibody(sdAbs) Drugs Sales by Application
2.5.4.1 Global Single Domain Antibody(sdAbs) Drugs Sale Market Share by Application (2021-2026)
2.5.4.2 Global Single Domain Antibody(sdAbs) Drugs Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Single Domain Antibody(sdAbs) Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Single Domain Antibody(sdAbs) Drugs Breakdown Data by Company
3.1.1 Global Single Domain Antibody(sdAbs) Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Single Domain Antibody(sdAbs) Drugs Sales Market Share by Company (2021-2026)
3.2 Global Single Domain Antibody(sdAbs) Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Single Domain Antibody(sdAbs) Drugs Revenue by Company (2021-2026)
3.2.2 Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Single Domain Antibody(sdAbs) Drugs Sale Price by Company
3.4 Key Manufacturers Single Domain Antibody(sdAbs) Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Single Domain Antibody(sdAbs) Drugs Product Location Distribution
3.4.2 Players Single Domain Antibody(sdAbs) Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SINGLE DOMAIN ANTIBODY(SDABS) DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Single Domain Antibody(sdAbs) Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Single Domain Antibody(sdAbs) Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Single Domain Antibody(sdAbs) Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Single Domain Antibody(sdAbs) Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Single Domain Antibody(sdAbs) Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Single Domain Antibody(sdAbs) Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Single Domain Antibody(sdAbs) Drugs Sales Growth
4.4 APAC Single Domain Antibody(sdAbs) Drugs Sales Growth
4.5 Europe Single Domain Antibody(sdAbs) Drugs Sales Growth
4.6 Middle East & Africa Single Domain Antibody(sdAbs) Drugs Sales Growth
5 AMERICAS
5.1 Americas Single Domain Antibody(sdAbs) Drugs Sales by Country
5.1.1 Americas Single Domain Antibody(sdAbs) Drugs Sales by Country (2021-2026)
5.1.2 Americas Single Domain Antibody(sdAbs) Drugs Revenue by Country (2021-2026)
5.2 Americas Single Domain Antibody(sdAbs) Drugs Sales by Type (2021-2026)
5.3 Americas Single Domain Antibody(sdAbs) Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Single Domain Antibody(sdAbs) Drugs Sales by Region
6.1.1 APAC Single Domain Antibody(sdAbs) Drugs Sales by Region (2021-2026)
6.1.2 APAC Single Domain Antibody(sdAbs) Drugs Revenue by Region (2021-2026)
6.2 APAC Single Domain Antibody(sdAbs) Drugs Sales by Type (2021-2026)
6.3 APAC Single Domain Antibody(sdAbs) Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Single Domain Antibody(sdAbs) Drugs by Country
7.1.1 Europe Single Domain Antibody(sdAbs) Drugs Sales by Country (2021-2026)
7.1.2 Europe Single Domain Antibody(sdAbs) Drugs Revenue by Country (2021-2026)
7.2 Europe Single Domain Antibody(sdAbs) Drugs Sales by Type (2021-2026)
7.3 Europe Single Domain Antibody(sdAbs) Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Single Domain Antibody(sdAbs) Drugs by Country
8.1.1 Middle East & Africa Single Domain Antibody(sdAbs) Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Single Domain Antibody(sdAbs) Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Single Domain Antibody(sdAbs) Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Single Domain Antibody(sdAbs) Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Single Domain Antibody(sdAbs) Drugs
10.3 Manufacturing Process Analysis of Single Domain Antibody(sdAbs) Drugs
10.4 Industry Chain Structure of Single Domain Antibody(sdAbs) Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Single Domain Antibody(sdAbs) Drugs Distributors
11.3 Single Domain Antibody(sdAbs) Drugs Customer
12 WORLD FORECAST REVIEW FOR SINGLE DOMAIN ANTIBODY(SDABS) DRUGS BY GEOGRAPHIC REGION
12.1 Global Single Domain Antibody(sdAbs) Drugs Market Size Forecast by Region
12.1.1 Global Single Domain Antibody(sdAbs) Drugs Forecast by Region (2027-2032)
12.1.2 Global Single Domain Antibody(sdAbs) Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Single Domain Antibody(sdAbs) Drugs Forecast by Type (2027-2032)
12.7 Global Single Domain Antibody(sdAbs) Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Single Domain Antibody(sdAbs) Drugs Product Portfolios and Specifications
13.1.3 Sanofi Single Domain Antibody(sdAbs) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 Taisho Pharmaceutical
13.2.1 Taisho Pharmaceutical Company Information
13.2.2 Taisho Pharmaceutical Single Domain Antibody(sdAbs) Drugs Product Portfolios and Specifications
13.2.3 Taisho Pharmaceutical Single Domain Antibody(sdAbs) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Taisho Pharmaceutical Main Business Overview
13.2.5 Taisho Pharmaceutical Latest Developments
13.3 Alphamab Oncology
13.3.1 Alphamab Oncology Company Information
13.3.2 Alphamab Oncology Single Domain Antibody(sdAbs) Drugs Product Portfolios and Specifications
13.3.3 Alphamab Oncology Single Domain Antibody(sdAbs) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Alphamab Oncology Main Business Overview
13.3.5 Alphamab Oncology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Single Domain Antibody(sdAbs) Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Single Domain Antibody(sdAbs) Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cablivi
Table 4. Major Players of Nanozora
Table 5. Major Players of Envafolimab
Table 6. Global Single Domain Antibody(sdAbs) Drugs Sales by Type (2021-2026) & (K Units)
Table 7. Global Single Domain Antibody(sdAbs) Drugs Sales Market Share by Type (2021-2026)
Table 8. Global Single Domain Antibody(sdAbs) Drugs Revenue by Type (2021-2026) & ($ million)
Table 9. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Type (2021-2026)
Table 10. Global Single Domain Antibody(sdAbs) Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Subcutaneous Injection
Table 12. Major Players of Intravenous Injection
Table 13. Major Players of Other
Table 14. Global Single Domain Antibody(sdAbs) Drugs Sales by Administration Route (2021-2026) & (K Units)
Table 15. Global Single Domain Antibody(sdAbs) Drugs Sales Market Share by Administration Route (2021-2026)
Table 16. Global Single Domain Antibody(sdAbs) Drugs Revenue by Administration Route (2021-2026) & ($ million)
Table 17. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Administration Route (2021-2026)
Table 18. Global Single Domain Antibody(sdAbs) Drugs Sale Price by Administration Route (2021-2026) & (US$/Unit)
Table 19. Major Players of Online Sales
Table 20. Major Players of Offline Sales
Table 21. Global Single Domain Antibody(sdAbs) Drugs Sales by Sales Channels (2021-2026) & (K Units)
Table 22. Global Single Domain Antibody(sdAbs) Drugs Sales Market Share by Sales Channels (2021-2026)
Table 23. Global Single Domain Antibody(sdAbs) Drugs Revenue by Sales Channels (2021-2026) & ($ million)
Table 24. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Sales Channels (2021-2026)
Table 25. Global Single Domain Antibody(sdAbs) Drugs Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 26. Global Single Domain Antibody(sdAbs) Drugs Sale by Application (2021-2026) & (K Units)
Table 27. Global Single Domain Antibody(sdAbs) Drugs Sale Market Share by Application (2021-2026)
Table 28. Global Single Domain Antibody(sdAbs) Drugs Revenue by Application (2021-2026) & ($ million)
Table 29. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Application (2021-2026)
Table 30. Global Single Domain Antibody(sdAbs) Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 31. Global Single Domain Antibody(sdAbs) Drugs Sales by Company (2021-2026) & (K Units)
Table 32. Global Single Domain Antibody(sdAbs) Drugs Sales Market Share by Company (2021-2026)
Table 33. Global Single Domain Antibody(sdAbs) Drugs Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Company (2021-2026)
Table 35. Global Single Domain Antibody(sdAbs) Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 36. Key Manufacturers Single Domain Antibody(sdAbs) Drugs Producing Area Distribution and Sales Area
Table 37. Players Single Domain Antibody(sdAbs) Drugs Products Offered
Table 38. Single Domain Antibody(sdAbs) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Single Domain Antibody(sdAbs) Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 42. Global Single Domain Antibody(sdAbs) Drugs Sales Market Share Geographic Region (2021-2026)
Table 43. Global Single Domain Antibody(sdAbs) Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Single Domain Antibody(sdAbs) Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 46. Global Single Domain Antibody(sdAbs) Drugs Sales Market Share by Country/Region (2021-2026)
Table 47. Global Single Domain Antibody(sdAbs) Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Single Domain Antibody(sdAbs) Drugs Sales by Country (2021-2026) & (K Units)
Table 50. Americas Single Domain Antibody(sdAbs) Drugs Sales Market Share by Country (2021-2026)
Table 51. Americas Single Domain Antibody(sdAbs) Drugs Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Single Domain Antibody(sdAbs) Drugs Sales by Type (2021-2026) & (K Units)
Table 53. Americas Single Domain Antibody(sdAbs) Drugs Sales by Application (2021-2026) & (K Units)
Table 54. APAC Single Domain Antibody(sdAbs) Drugs Sales by Region (2021-2026) & (K Units)
Table 55. APAC Single Domain Antibody(sdAbs) Drugs Sales Market Share by Region (2021-2026)
Table 56. APAC Single Domain Antibody(sdAbs) Drugs Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Single Domain Antibody(sdAbs) Drugs Sales by Type (2021-2026) & (K Units)
Table 58. APAC Single Domain Antibody(sdAbs) Drugs Sales by Application (2021-2026) & (K Units)
Table 59. Europe Single Domain Antibody(sdAbs) Drugs Sales by Country (2021-2026) & (K Units)
Table 60. Europe Single Domain Antibody(sdAbs) Drugs Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Single Domain Antibody(sdAbs) Drugs Sales by Type (2021-2026) & (K Units)
Table 62. Europe Single Domain Antibody(sdAbs) Drugs Sales by Application (2021-2026) & (K Units)
Table 63. Middle East & Africa Single Domain Antibody(sdAbs) Drugs Sales by Country (2021-2026) & (K Units)
Table 64. Middle East & Africa Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Single Domain Antibody(sdAbs) Drugs Sales by Type (2021-2026) & (K Units)
Table 66. Middle East & Africa Single Domain Antibody(sdAbs) Drugs Sales by Application (2021-2026) & (K Units)
Table 67. Key Market Drivers & Growth Opportunities of Single Domain Antibody(sdAbs) Drugs
Table 68. Key Market Challenges & Risks of Single Domain Antibody(sdAbs) Drugs
Table 69. Key Industry Trends of Single Domain Antibody(sdAbs) Drugs
Table 70. Single Domain Antibody(sdAbs) Drugs Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Single Domain Antibody(sdAbs) Drugs Distributors List
Table 73. Single Domain Antibody(sdAbs) Drugs Customer List
Table 74. Global Single Domain Antibody(sdAbs) Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 75. Global Single Domain Antibody(sdAbs) Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Single Domain Antibody(sdAbs) Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 77. Americas Single Domain Antibody(sdAbs) Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Single Domain Antibody(sdAbs) Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 79. APAC Single Domain Antibody(sdAbs) Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Single Domain Antibody(sdAbs) Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Europe Single Domain Antibody(sdAbs) Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Single Domain Antibody(sdAbs) Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 83. Middle East & Africa Single Domain Antibody(sdAbs) Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Single Domain Antibody(sdAbs) Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 85. Global Single Domain Antibody(sdAbs) Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Single Domain Antibody(sdAbs) Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 87. Global Single Domain Antibody(sdAbs) Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. Sanofi Basic Information, Single Domain Antibody(sdAbs) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofi Single Domain Antibody(sdAbs) Drugs Product Portfolios and Specifications
Table 90. Sanofi Single Domain Antibody(sdAbs) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Sanofi Main Business
Table 92. Sanofi Latest Developments
Table 93. Taisho Pharmaceutical Basic Information, Single Domain Antibody(sdAbs) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Taisho Pharmaceutical Single Domain Antibody(sdAbs) Drugs Product Portfolios and Specifications
Table 95. Taisho Pharmaceutical Single Domain Antibody(sdAbs) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Taisho Pharmaceutical Main Business
Table 97. Taisho Pharmaceutical Latest Developments
Table 98. Alphamab Oncology Basic Information, Single Domain Antibody(sdAbs) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Alphamab Oncology Single Domain Antibody(sdAbs) Drugs Product Portfolios and Specifications
Table 100. Alphamab Oncology Single Domain Antibody(sdAbs) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Alphamab Oncology Main Business
Table 102. Alphamab Oncology Latest Developments
Table 1. Single Domain Antibody(sdAbs) Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Single Domain Antibody(sdAbs) Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cablivi
Table 4. Major Players of Nanozora
Table 5. Major Players of Envafolimab
Table 6. Global Single Domain Antibody(sdAbs) Drugs Sales by Type (2021-2026) & (K Units)
Table 7. Global Single Domain Antibody(sdAbs) Drugs Sales Market Share by Type (2021-2026)
Table 8. Global Single Domain Antibody(sdAbs) Drugs Revenue by Type (2021-2026) & ($ million)
Table 9. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Type (2021-2026)
Table 10. Global Single Domain Antibody(sdAbs) Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Subcutaneous Injection
Table 12. Major Players of Intravenous Injection
Table 13. Major Players of Other
Table 14. Global Single Domain Antibody(sdAbs) Drugs Sales by Administration Route (2021-2026) & (K Units)
Table 15. Global Single Domain Antibody(sdAbs) Drugs Sales Market Share by Administration Route (2021-2026)
Table 16. Global Single Domain Antibody(sdAbs) Drugs Revenue by Administration Route (2021-2026) & ($ million)
Table 17. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Administration Route (2021-2026)
Table 18. Global Single Domain Antibody(sdAbs) Drugs Sale Price by Administration Route (2021-2026) & (US$/Unit)
Table 19. Major Players of Online Sales
Table 20. Major Players of Offline Sales
Table 21. Global Single Domain Antibody(sdAbs) Drugs Sales by Sales Channels (2021-2026) & (K Units)
Table 22. Global Single Domain Antibody(sdAbs) Drugs Sales Market Share by Sales Channels (2021-2026)
Table 23. Global Single Domain Antibody(sdAbs) Drugs Revenue by Sales Channels (2021-2026) & ($ million)
Table 24. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Sales Channels (2021-2026)
Table 25. Global Single Domain Antibody(sdAbs) Drugs Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 26. Global Single Domain Antibody(sdAbs) Drugs Sale by Application (2021-2026) & (K Units)
Table 27. Global Single Domain Antibody(sdAbs) Drugs Sale Market Share by Application (2021-2026)
Table 28. Global Single Domain Antibody(sdAbs) Drugs Revenue by Application (2021-2026) & ($ million)
Table 29. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Application (2021-2026)
Table 30. Global Single Domain Antibody(sdAbs) Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 31. Global Single Domain Antibody(sdAbs) Drugs Sales by Company (2021-2026) & (K Units)
Table 32. Global Single Domain Antibody(sdAbs) Drugs Sales Market Share by Company (2021-2026)
Table 33. Global Single Domain Antibody(sdAbs) Drugs Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Company (2021-2026)
Table 35. Global Single Domain Antibody(sdAbs) Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 36. Key Manufacturers Single Domain Antibody(sdAbs) Drugs Producing Area Distribution and Sales Area
Table 37. Players Single Domain Antibody(sdAbs) Drugs Products Offered
Table 38. Single Domain Antibody(sdAbs) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Single Domain Antibody(sdAbs) Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 42. Global Single Domain Antibody(sdAbs) Drugs Sales Market Share Geographic Region (2021-2026)
Table 43. Global Single Domain Antibody(sdAbs) Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Single Domain Antibody(sdAbs) Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 46. Global Single Domain Antibody(sdAbs) Drugs Sales Market Share by Country/Region (2021-2026)
Table 47. Global Single Domain Antibody(sdAbs) Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Single Domain Antibody(sdAbs) Drugs Sales by Country (2021-2026) & (K Units)
Table 50. Americas Single Domain Antibody(sdAbs) Drugs Sales Market Share by Country (2021-2026)
Table 51. Americas Single Domain Antibody(sdAbs) Drugs Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Single Domain Antibody(sdAbs) Drugs Sales by Type (2021-2026) & (K Units)
Table 53. Americas Single Domain Antibody(sdAbs) Drugs Sales by Application (2021-2026) & (K Units)
Table 54. APAC Single Domain Antibody(sdAbs) Drugs Sales by Region (2021-2026) & (K Units)
Table 55. APAC Single Domain Antibody(sdAbs) Drugs Sales Market Share by Region (2021-2026)
Table 56. APAC Single Domain Antibody(sdAbs) Drugs Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Single Domain Antibody(sdAbs) Drugs Sales by Type (2021-2026) & (K Units)
Table 58. APAC Single Domain Antibody(sdAbs) Drugs Sales by Application (2021-2026) & (K Units)
Table 59. Europe Single Domain Antibody(sdAbs) Drugs Sales by Country (2021-2026) & (K Units)
Table 60. Europe Single Domain Antibody(sdAbs) Drugs Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Single Domain Antibody(sdAbs) Drugs Sales by Type (2021-2026) & (K Units)
Table 62. Europe Single Domain Antibody(sdAbs) Drugs Sales by Application (2021-2026) & (K Units)
Table 63. Middle East & Africa Single Domain Antibody(sdAbs) Drugs Sales by Country (2021-2026) & (K Units)
Table 64. Middle East & Africa Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Single Domain Antibody(sdAbs) Drugs Sales by Type (2021-2026) & (K Units)
Table 66. Middle East & Africa Single Domain Antibody(sdAbs) Drugs Sales by Application (2021-2026) & (K Units)
Table 67. Key Market Drivers & Growth Opportunities of Single Domain Antibody(sdAbs) Drugs
Table 68. Key Market Challenges & Risks of Single Domain Antibody(sdAbs) Drugs
Table 69. Key Industry Trends of Single Domain Antibody(sdAbs) Drugs
Table 70. Single Domain Antibody(sdAbs) Drugs Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Single Domain Antibody(sdAbs) Drugs Distributors List
Table 73. Single Domain Antibody(sdAbs) Drugs Customer List
Table 74. Global Single Domain Antibody(sdAbs) Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 75. Global Single Domain Antibody(sdAbs) Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Single Domain Antibody(sdAbs) Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 77. Americas Single Domain Antibody(sdAbs) Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Single Domain Antibody(sdAbs) Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 79. APAC Single Domain Antibody(sdAbs) Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Single Domain Antibody(sdAbs) Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Europe Single Domain Antibody(sdAbs) Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Single Domain Antibody(sdAbs) Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 83. Middle East & Africa Single Domain Antibody(sdAbs) Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Single Domain Antibody(sdAbs) Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 85. Global Single Domain Antibody(sdAbs) Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Single Domain Antibody(sdAbs) Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 87. Global Single Domain Antibody(sdAbs) Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. Sanofi Basic Information, Single Domain Antibody(sdAbs) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofi Single Domain Antibody(sdAbs) Drugs Product Portfolios and Specifications
Table 90. Sanofi Single Domain Antibody(sdAbs) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Sanofi Main Business
Table 92. Sanofi Latest Developments
Table 93. Taisho Pharmaceutical Basic Information, Single Domain Antibody(sdAbs) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Taisho Pharmaceutical Single Domain Antibody(sdAbs) Drugs Product Portfolios and Specifications
Table 95. Taisho Pharmaceutical Single Domain Antibody(sdAbs) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Taisho Pharmaceutical Main Business
Table 97. Taisho Pharmaceutical Latest Developments
Table 98. Alphamab Oncology Basic Information, Single Domain Antibody(sdAbs) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Alphamab Oncology Single Domain Antibody(sdAbs) Drugs Product Portfolios and Specifications
Table 100. Alphamab Oncology Single Domain Antibody(sdAbs) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Alphamab Oncology Main Business
Table 102. Alphamab Oncology Latest Developments
LIST OF FIGURES
Figure 1. Picture of Single Domain Antibody(sdAbs) Drugs
Figure 2. Single Domain Antibody(sdAbs) Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Single Domain Antibody(sdAbs) Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Single Domain Antibody(sdAbs) Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Single Domain Antibody(sdAbs) Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Single Domain Antibody(sdAbs) Drugs Sales Market Share by Country/Region (2025)
Figure 10. Single Domain Antibody(sdAbs) Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Cablivi
Figure 12. Product Picture of Nanozora
Figure 13. Product Picture of Envafolimab
Figure 14. Global Single Domain Antibody(sdAbs) Drugs Sales Market Share by Type in 2026
Figure 15. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Subcutaneous Injection
Figure 17. Product Picture of Intravenous Injection
Figure 18. Product Picture of Other
Figure 19. Global Single Domain Antibody(sdAbs) Drugs Sales Market Share by Administration Route in 2026
Figure 20. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Administration Route (2021-2026)
Figure 21. Product Picture of Online Sales
Figure 22. Product Picture of Offline Sales
Figure 23. Global Single Domain Antibody(sdAbs) Drugs Sales Market Share by Sales Channels in 2026
Figure 24. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Sales Channels (2021-2026)
Figure 25. Single Domain Antibody(sdAbs) Drugs Consumed in Hospital
Figure 26. Global Single Domain Antibody(sdAbs) Drugs Market: Hospital (2021-2026) & (K Units)
Figure 27. Single Domain Antibody(sdAbs) Drugs Consumed in Clinic
Figure 28. Global Single Domain Antibody(sdAbs) Drugs Market: Clinic (2021-2026) & (K Units)
Figure 29. Single Domain Antibody(sdAbs) Drugs Consumed in Other
Figure 30. Global Single Domain Antibody(sdAbs) Drugs Market: Other (2021-2026) & (K Units)
Figure 31. Global Single Domain Antibody(sdAbs) Drugs Sale Market Share by Application (2025)
Figure 32. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Application in 2025
Figure 33. Single Domain Antibody(sdAbs) Drugs Sales by Company in 2025 (K Units)
Figure 34. Global Single Domain Antibody(sdAbs) Drugs Sales Market Share by Company in 2025
Figure 35. Single Domain Antibody(sdAbs) Drugs Revenue by Company in 2025 ($ millions)
Figure 36. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Company in 2025
Figure 37. Global Single Domain Antibody(sdAbs) Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Geographic Region in 2025
Figure 39. Americas Single Domain Antibody(sdAbs) Drugs Sales 2021-2026 (K Units)
Figure 40. Americas Single Domain Antibody(sdAbs) Drugs Revenue 2021-2026 ($ millions)
Figure 41. APAC Single Domain Antibody(sdAbs) Drugs Sales 2021-2026 (K Units)
Figure 42. APAC Single Domain Antibody(sdAbs) Drugs Revenue 2021-2026 ($ millions)
Figure 43. Europe Single Domain Antibody(sdAbs) Drugs Sales 2021-2026 (K Units)
Figure 44. Europe Single Domain Antibody(sdAbs) Drugs Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Single Domain Antibody(sdAbs) Drugs Sales 2021-2026 (K Units)
Figure 46. Middle East & Africa Single Domain Antibody(sdAbs) Drugs Revenue 2021-2026 ($ millions)
Figure 47. Americas Single Domain Antibody(sdAbs) Drugs Sales Market Share by Country in 2025
Figure 48. Americas Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Country (2021-2026)
Figure 49. Americas Single Domain Antibody(sdAbs) Drugs Sales Market Share by Type (2021-2026)
Figure 50. Americas Single Domain Antibody(sdAbs) Drugs Sales Market Share by Application (2021-2026)
Figure 51. United States Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Single Domain Antibody(sdAbs) Drugs Sales Market Share by Region in 2025
Figure 56. APAC Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Region (2021-2026)
Figure 57. APAC Single Domain Antibody(sdAbs) Drugs Sales Market Share by Type (2021-2026)
Figure 58. APAC Single Domain Antibody(sdAbs) Drugs Sales Market Share by Application (2021-2026)
Figure 59. China Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. India Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Single Domain Antibody(sdAbs) Drugs Sales Market Share by Country in 2025
Figure 67. Europe Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Country (2021-2026)
Figure 68. Europe Single Domain Antibody(sdAbs) Drugs Sales Market Share by Type (2021-2026)
Figure 69. Europe Single Domain Antibody(sdAbs) Drugs Sales Market Share by Application (2021-2026)
Figure 70. Germany Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. France Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Single Domain Antibody(sdAbs) Drugs Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Single Domain Antibody(sdAbs) Drugs Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Single Domain Antibody(sdAbs) Drugs Sales Market Share by Application (2021-2026)
Figure 78. Egypt Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Single Domain Antibody(sdAbs) Drugs in 2026
Figure 84. Manufacturing Process Analysis of Single Domain Antibody(sdAbs) Drugs
Figure 85. Industry Chain Structure of Single Domain Antibody(sdAbs) Drugs
Figure 86. Channels of Distribution
Figure 87. Global Single Domain Antibody(sdAbs) Drugs Sales Market Forecast by Region (2027-2032)
Figure 88. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Single Domain Antibody(sdAbs) Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Single Domain Antibody(sdAbs) Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Single Domain Antibody(sdAbs) Drugs
Figure 2. Single Domain Antibody(sdAbs) Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Single Domain Antibody(sdAbs) Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Single Domain Antibody(sdAbs) Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Single Domain Antibody(sdAbs) Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Single Domain Antibody(sdAbs) Drugs Sales Market Share by Country/Region (2025)
Figure 10. Single Domain Antibody(sdAbs) Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Cablivi
Figure 12. Product Picture of Nanozora
Figure 13. Product Picture of Envafolimab
Figure 14. Global Single Domain Antibody(sdAbs) Drugs Sales Market Share by Type in 2026
Figure 15. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Subcutaneous Injection
Figure 17. Product Picture of Intravenous Injection
Figure 18. Product Picture of Other
Figure 19. Global Single Domain Antibody(sdAbs) Drugs Sales Market Share by Administration Route in 2026
Figure 20. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Administration Route (2021-2026)
Figure 21. Product Picture of Online Sales
Figure 22. Product Picture of Offline Sales
Figure 23. Global Single Domain Antibody(sdAbs) Drugs Sales Market Share by Sales Channels in 2026
Figure 24. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Sales Channels (2021-2026)
Figure 25. Single Domain Antibody(sdAbs) Drugs Consumed in Hospital
Figure 26. Global Single Domain Antibody(sdAbs) Drugs Market: Hospital (2021-2026) & (K Units)
Figure 27. Single Domain Antibody(sdAbs) Drugs Consumed in Clinic
Figure 28. Global Single Domain Antibody(sdAbs) Drugs Market: Clinic (2021-2026) & (K Units)
Figure 29. Single Domain Antibody(sdAbs) Drugs Consumed in Other
Figure 30. Global Single Domain Antibody(sdAbs) Drugs Market: Other (2021-2026) & (K Units)
Figure 31. Global Single Domain Antibody(sdAbs) Drugs Sale Market Share by Application (2025)
Figure 32. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Application in 2025
Figure 33. Single Domain Antibody(sdAbs) Drugs Sales by Company in 2025 (K Units)
Figure 34. Global Single Domain Antibody(sdAbs) Drugs Sales Market Share by Company in 2025
Figure 35. Single Domain Antibody(sdAbs) Drugs Revenue by Company in 2025 ($ millions)
Figure 36. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Company in 2025
Figure 37. Global Single Domain Antibody(sdAbs) Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Geographic Region in 2025
Figure 39. Americas Single Domain Antibody(sdAbs) Drugs Sales 2021-2026 (K Units)
Figure 40. Americas Single Domain Antibody(sdAbs) Drugs Revenue 2021-2026 ($ millions)
Figure 41. APAC Single Domain Antibody(sdAbs) Drugs Sales 2021-2026 (K Units)
Figure 42. APAC Single Domain Antibody(sdAbs) Drugs Revenue 2021-2026 ($ millions)
Figure 43. Europe Single Domain Antibody(sdAbs) Drugs Sales 2021-2026 (K Units)
Figure 44. Europe Single Domain Antibody(sdAbs) Drugs Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Single Domain Antibody(sdAbs) Drugs Sales 2021-2026 (K Units)
Figure 46. Middle East & Africa Single Domain Antibody(sdAbs) Drugs Revenue 2021-2026 ($ millions)
Figure 47. Americas Single Domain Antibody(sdAbs) Drugs Sales Market Share by Country in 2025
Figure 48. Americas Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Country (2021-2026)
Figure 49. Americas Single Domain Antibody(sdAbs) Drugs Sales Market Share by Type (2021-2026)
Figure 50. Americas Single Domain Antibody(sdAbs) Drugs Sales Market Share by Application (2021-2026)
Figure 51. United States Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Single Domain Antibody(sdAbs) Drugs Sales Market Share by Region in 2025
Figure 56. APAC Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Region (2021-2026)
Figure 57. APAC Single Domain Antibody(sdAbs) Drugs Sales Market Share by Type (2021-2026)
Figure 58. APAC Single Domain Antibody(sdAbs) Drugs Sales Market Share by Application (2021-2026)
Figure 59. China Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. India Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Single Domain Antibody(sdAbs) Drugs Sales Market Share by Country in 2025
Figure 67. Europe Single Domain Antibody(sdAbs) Drugs Revenue Market Share by Country (2021-2026)
Figure 68. Europe Single Domain Antibody(sdAbs) Drugs Sales Market Share by Type (2021-2026)
Figure 69. Europe Single Domain Antibody(sdAbs) Drugs Sales Market Share by Application (2021-2026)
Figure 70. Germany Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. France Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Single Domain Antibody(sdAbs) Drugs Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Single Domain Antibody(sdAbs) Drugs Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Single Domain Antibody(sdAbs) Drugs Sales Market Share by Application (2021-2026)
Figure 78. Egypt Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Single Domain Antibody(sdAbs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Single Domain Antibody(sdAbs) Drugs in 2026
Figure 84. Manufacturing Process Analysis of Single Domain Antibody(sdAbs) Drugs
Figure 85. Industry Chain Structure of Single Domain Antibody(sdAbs) Drugs
Figure 86. Channels of Distribution
Figure 87. Global Single Domain Antibody(sdAbs) Drugs Sales Market Forecast by Region (2027-2032)
Figure 88. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Single Domain Antibody(sdAbs) Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Single Domain Antibody(sdAbs) Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Single Domain Antibody(sdAbs) Drugs Revenue Market Share Forecast by Application (2027-2032)
